DTCX shares are tumbling approximately 28% in Friday's premarket session, with the stock indicated near $2.22 after closing at $3.09 on Thursday, March 26. The primary catalyst is the after-hours announcement of a dilutive confidentially marketed public offering priced at $2.00 per share — a steep discount of approximately 35% to the prior session's close.
AAOI shares are indicated about 13% lower in Thursday premarket trading after closing the most recent session near $105.14, down from a prior close of $111.66.
The pullback comes on the heels of a powerful price rally in March, including a recent 12% intraday jump after a bullish trading-signal article highlighted strong “power inflow” into the stock.
Megan Holdings Limited (MGN) shares collapsed about 92.10% in the most recent completed session, plunging from a prior close of $4.24 to approximately $0.34.
The move wiped out more than $160 million in market capitalization in a single day and pushed the stock to the bottom of its 52‑week range.
Pony AI Inc. (PONY) closed the most recent session at $11.39, up 5.3% from $10.80 the prior day, but is indicated down about 16% in Thursday premarket trading, pointing to a move into the mid‑$9 range.
The sharp premarket drop follows a multi‑day run-up supported by very strong Q4 2025 robotaxi revenue growth and a swing to quarterly profitability, leaving the stock vulnerable to profit-taking and volatility.
VICR shares are indicated about 9% lower in Thursday premarket trading after closing the prior session at $186.00.
The pullback follows a powerful rally that has seen the stock gain more than 230% over the past year and about 250% over six months, leaving it vulnerable to profit-taking.
Shares of Avis Budget Group (CAR) are surging approximately +15% in Thursday's trading session, with the stock last trading near $142.09 versus a prior close of $123.56. The rally appears driven by a combination of a short squeeze, continued momentum from Deutsche Bank's maintained Buy rating, and the dismissal of two significant shareholder lawsuits.
I've been following
AST SpaceMobile (ASTS) closely, and the stock has shown notable volatility in recent sessions. This comes amid impressive revenue beats and key satellite milestones that have driven sharp gains after major announcements. Investor interest seems tied to the company's shift toward revenue generation and constellation growth, amplified by broader space sector momentum—including speculation around SpaceX developments. That said, we've seen pullbacks due to insider sales and questions around execution, with shares trading in a broad range lately. From what I see, the strong partner ecosystem—covering billions of subscribers—and solid liquidity position
ASTS well for growth in direct-to-device satellite broadband. Capital intensity remains something to watch in this market environment.
PGEN shares are surging approximately +30% in Thursday's trading session, from a prior close of $3.10 to approximately $4.03, as of mid-session on March 26, 2026. The primary catalyst is Precigen's blockbuster Q1 2026 revenue guidance — the company expects Q1 revenue to exceed $18 million, a staggering 429% sequential increase from Q4 2025's $3.4 million.
Shares of Lam Research Corporation (LRCX) are declining approximately 5.00% in today's session (March 26, 2026), with shares trading near $221.78, down from the prior session's close of $233.45. The primary catalyst is a broad-based semiconductor sector sell-off, driven by renewed tariff escalation fears and macro uncertainty ahead of potential new trade policy announcements.
Worthington Steel shares tumbled approximately 18% in premarket trading on March 26, 2026, following a deeply disappointing fiscal third-quarter earnings report released after the close on March 25. The company reported adjusted EPS of $0.27, missing the Wall Street consensus of $0.47 by $0.20 — a shortfall of more than 40%.
KOD shares surged approximately +50% in premarket trading on Thursday, March 26, 2026, from a prior closing price of $22.75 to approximately $34.13. The primary catalyst is a landmark readout: the GLOW2 Phase 3 trial of Zenkuda (tarcocimab tedromer) in diabetic retinopathy met its primary endpoint with overwhelming statistical significance.
APP is trading approximately 6% lower in premarket trading on March 26, 2026, extending a multi-session losing streak. The prior regular-session close (March 25, 2026) stood at $435.91, itself already down 5.02% from the day before, making the premarket slide a continuation of accelerating selling pressure.
Wave Life Sciences (WVE) shares are tumbling approximately 51% in premarket trading on March 26, 2026, from a prior close of $12.30 to approximately $6.03. The primary catalyst is the release of highly anticipated INLIGHT Phase 1 clinical data for WVE-007, the company's investigational INHBE GalNAc-siRNA obesity treatment, with results falling materially short of investor expectations.
MLKN shares are down approximately 18.90% in premarket trading on March 26, 2026, falling to $15.70 from the prior session's close of $19.36. The primary catalyst is a double miss on both earnings and revenue in the company's fiscal Q3 2026 report released after the close on March 25.
TASK shares are down approximately -36% in premarket trading on March 26, 2026, the stock's official ex-dividend date for its special $3.65 per share cash dividend. The $3.65 special cash dividend — exceeding 25% of the stock's pre-ex-div market value — triggered a mandatory Nasdaq-prescribed price adjustment on today's open.
OLPX surged approximately +50.38% in premarket trading on March 26, 2026, from a previous close of $1.33 to approximately $2.00, with an intraday premarket high of $2.03. The primary catalyst is a definitive acquisition agreement by German consumer goods giant Henkel AG to purchase Olaplex for $2.06 per share in an all-cash deal, valuing the company at approximately $1.4 billion.
NAVN shares are surging approximately +25% in premarket trading on March 26, 2026, following a blockbuster earnings report released after the close of the prior session. Primary catalyst: Q4 fiscal year 2026 results delivered a significant beat — revenue of $178 million rose 35% year-over-year, surpassing analyst forecasts by nearly 10%.
AUGO shares are trading roughly 9% higher in Wednesday action, moving from a prior close of $66.42 to around $72.40 intraday.
The stock’s advance extends a powerful year-long rally underpinned by record 2025 production, surging Adjusted EBITDA, and a recently declared cash dividend of $0.66 per share.
AVXL shares are indicated down about 33% in Wednesday’s premarket session, after closing the prior regular session at $4.19.
The slide follows a recent drop triggered by a wider‑than‑expected fourth‑quarter loss and ongoing questions about the company’s late‑stage neurology pipeline.
One & One Green Technologies Inc. (YDDL) shares are indicated down about 13% in Wednesday’s premarket session after closing the prior regular session at $12.00.
The stock had just surged 15.6% in the latest completed session, jumping from a prior close of $10.38 to $12.00, leaving it vulnerable to swift profit‑taking and volatility.